Duke Center for Brain and Spine Metastasis at DCI is the most comprehensive destination site for patients with brain and/or spinal metastases or leptomeningeal disease (LMD).
The center is comprised of known thought leaders in their respective fields. A wide variety of research projects and initiatives are underway to help better understand brain and spine metastasis, a problem of major medical and scientific importance.
Duke is at the forefront of international brain tumor research and treatment. That recognition extends to the specialists who treat people with metastatic brain and spine tumors.
David Ashley, MBBS, PhD; Michael B. Kastan, MD, PhD; and John Sampson, MD, PhD; make up the center's executive leadership team.
Peter E. Fecci, MD, PhD :: Brain
Patrick J. Codd, MD :: Brain
John H. Sampson, MD, PhD, :: Brain
Steve H Cook, MD :: Brain
C. Rory Goodwin, MD, PhD :: Spine
Chester Yarbrough, MD :: Spine
Isaac O. Karikari, MD :: Spine
John C Barr, MD :: Spine
Muhammad Abd-El-Barr, MD, PhD :: Spine
Denise M. Lally-Goss, MSN, ANP-C, GNP-C
Brice D. Painter, PA-C, MHS
Sergio A. Mendoza Lattes, MD
Carey Anders, MD :: Breast
Sarah L. Sammons, MD :: Breast
Jeffrey M. Clarke, MD :: Lung
April K.S. Salama, MD :: Melanoma
Daniel J. George, MD :: GU
John H. Strickler, MD :: GI
Rebecca A. Previs, MD :: GYN
Jennie Petruney, MSN, ANP-BC